Jennerex Announces Presentations at Upcoming Conferences


<p><location>SAN FRANCISCO</location>, <chron>Dec. 23</chron> /CNW/ -- Jennerex Biotherapeutics, a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced that management will present at the following upcoming investor conferences.</p>
<p> </p>
<p> </p>
    Biotech Showcase 2010
    Tuesday, January 12, 2010
    9:40 a.m. PT
    Marines' Memorial Club and Hotel, San Francisco
<p> </p>
    OneMedForum 2010
    Wednesday, January 13, 2010
    2:40 p.m. PT
    Sir Francis Drake Hotel, San Francisco

    About Jennerex
<p>Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common cancers. Jennerex's products target, attack and eradicate cancers through a novel and potent oncolytic mechanism that is dependent on highly-specific replication of the Company's poxviruses in cancer cells. These products not only cause cancer cell lysis thereby killing through replication, they simultaneously shut-off the blood supply to tumors, as well as stimulating the body's immune response to the cancer. Jennerex, Inc. is headquartered in <location>San Francisco</location> and has manufacturing and research activities based at the <location>Ottawa</location> Hospital Research Institute in <location>Ottawa</location>, <location>Canada</location>. For more information about Jennerex and the Company's pipeline of three clinical-stage products, please visit <a href=""></a> .</p>


For further information: For further information: Jennifer Cook Williams of Cook Williams Communications, Inc., +1-360-668-3701,, for Jennerex Biotherapeutics Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890